Accelerate Diagnostics (AXDX) Competitors

Accelerate Diagnostics (NASDAQ:AXDX) and Berkeley Lights (NASDAQ:BLI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, community ranking, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk.

Which has stronger valuation and earnings, AXDX or BLI?

Accelerate Diagnostics has higher earnings, but lower revenue than Berkeley Lights. Accelerate Diagnostics is trading at a lower price-to-earnings ratio than Berkeley Lights, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accelerate Diagnostics	$12.06M	2.29	-$61.62M	-$4.07	-0.31
Berkeley Lights	$78.60M	0.00	-$98.04M	-$1.43	N/A

Do institutionals and insiders hold more shares of AXDX or BLI?

17.1% of Accelerate Diagnostics shares are held by institutional investors. Comparatively, 68.4% of Berkeley Lights shares are held by institutional investors. 43.6% of Accelerate Diagnostics shares are held by insiders. Comparatively, 17.6% of Berkeley Lights shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Do analysts rate AXDX or BLI?

Accelerate Diagnostics presently has a consensus price target of $1.00, indicating a potential downside of 25.37%.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accelerate Diagnostics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Berkeley Lights	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the media prefer AXDX or BLI?

In the previous week, Accelerate Diagnostics had 1 more articles in the media than Berkeley Lights. MarketBeat recorded 1 mentions for Accelerate Diagnostics and 0 mentions for Berkeley Lights. Accelerate Diagnostics' average media sentiment score of 0.49 beat Berkeley Lights' score of 0.00 indicating that Accelerate Diagnostics is being referred to more favorably in the media.

Company	Overall Sentiment
Accelerate Diagnostics	Neutral
Berkeley Lights	Neutral

Is AXDX or BLI more profitable?

Berkeley Lights has a net margin of -124.74% compared to Accelerate Diagnostics' net margin of -452.28%. Accelerate Diagnostics' return on equity of 0.00% beat Berkeley Lights' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Accelerate Diagnostics	-452.28%	N/A	-205.15%
Berkeley Lights	-124.74%	-57.56%	-39.40%

Which has more risk and volatility, AXDX or BLI?

Accelerate Diagnostics has a beta of 0.64, indicating that its share price is 36% less volatile than the S&P 500. Comparatively, Berkeley Lights has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500.

Does the MarketBeat Community favor AXDX or BLI?

Accelerate Diagnostics received 346 more outperform votes than Berkeley Lights when rated by MarketBeat users. Likewise, 62.88% of users gave Accelerate Diagnostics an outperform vote while only 26.67% of users gave Berkeley Lights an outperform vote.

Company	Underperform	Outperform
Accelerate Diagnostics	Outperform Votes 354 62.88%	Underperform Votes 209 37.12%
Berkeley Lights	Outperform Votes 8 26.67%	Underperform Votes 22 73.33%

Summary

Accelerate Diagnostics beats Berkeley Lights on 9 of the 15 factors compared between the two stocks.